Stealth BioTherapeutics
- Country USA
Upcoming Events
Past Events
Event Functions
Additional Functions
24
Mar 22
Stealth BioTherapeutics
KOL Discussion on the Potential of Elamipretide in Treatment of Geographic Atrophy in AMD
11
Nov 21
Stealth BioTherapeutics
Third Quarter 2021 Financial Results and Business Highlights Conference Call
13
Sep 21
Stealth BioTherapeutics
H.C. Wainwright 23rd Annual Global Investment Conference Presentation
05
Aug 21
Stealth BioTherapeutics
Second Quarter 2021 Financial Results and Business Highlights Conference Call
18
May 21
Stealth BioTherapeutics
First Quarter 2021 Financial Results and Business Highlights Conference Call
06
Apr 21
Stealth BioTherapeutics
Fiscal Year 2020 Financial Results and Business Highlights Conference Call
06
Jan 21
Stealth BioTherapeutics
Stealth BioTherapeutics Granted Type B Pre-NDA Meeting for Elamipretide as a Treatment for Barth Syndrome at 8:30 a.m. ET
Dial in: US toll free: 877-407-0989
International: +1-201-389-0921
05
Nov 20
Stealth BioTherapeutics
Stealth BioTherapeutics to Report Third Quarter 2020 Financial Results at 8:30am EST
23
Sep 20
Stealth BioTherapeutics
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit at 1:40 pm ET
15
Sep 20
Stealth BioTherapeutics
Cantor Fitzgerald’s Virtual Global Healthcare Conference 2020 8:40 am ET
14
Sep 20
Stealth BioTherapeutics
Stealth BioTherapeutics Presentation: H.C. Wainwright 22nd Annual Global Investment Conference at 4:30 pm ET
06
Aug 20
Stealth BioTherapeutics
Stealth BioTherapeutics to Report Second Quarter 2020 Financial Results at 8:30am EST
23
Jun 20
Stealth BioTherapeutics
Stealth BioTherapeutics Fireside Chat: BMO 2020 Prescriptions for Success Healthcare Virtual Conference at 3:00pm EST
02
Jun 20
Stealth BioTherapeutics
Stealth BioTherapeutics Presentation: Jefferies 2020 Healthcare Conference at 4:30pm EST
07
May 20
Stealth BioTherapeutics
First Quarter 2020 Financial Results and Recent Business Highlights at 8:30am ET
04
Mar 20
Stealth BioTherapeutics
Stealth BioTherapeutics Presentation at 40th Annual Cowen Health Care Conference
18
Feb 20
Stealth BioTherapeutics
Barth Syndrome Efficacy Study Using Natural History Data as a Control
10
Oct 19
Stealth BioTherapeutics
Stealth Announces Co-Development Partnership with Alexion for Mitochondrial Disease
Latest News
Latest Reports
Latest Research
Latest Webcasts
Event Functions
Additional Functions
11
Nov 21
Stealth BioTherapeutics
Third Quarter 2021 Financial Results and Business Highlights Conference Call